CEREBROSPINAL-FLUID AND HUMAN-IMMUNODEFICIENCY-VIRUS - FINDINGS IN HEALTHY, ASYMPTOMATIC, SEROPOSITIVE MEN

被引:13
|
作者
CHALMERS, AC [1 ]
APRILL, BS [1 ]
SHEPHARD, H [1 ]
机构
[1] CALIF STATE VIRAL & RICKETTSIAL LAB,BERKELEY,CA
关键词
D O I
10.1001/archinte.150.7.1538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Involvement of the central nervous system by human immunodeficiency virus is an important cause of morbidity and mortality. We have undertaken a longitudinal study of asymptomatic individuals found to be human immunodeficiency virus seropositive to identify and characterize cerebrospinal fluid abnormalities early in the disease process. Our findings in 25 individuals have been notably for a frequent incidence of cerebrospinal fluid abnormalities. Pleocytosis or elevated cerebrospinal fluid protein was found in 12 (48%) of 15 patients studied. Oligoclonal banding was present in 6 (26%) of 23 patients. Human immunodeficiency virus was isolated by culture in 4 asymptomatic patients. The cerebrospinal fluid abnormalities we observed indicate an active process occurring in the central nervous system, even in early human immunodeficiency virus infection in asymptomatic patients. Serial observation of these patients for development of neuropsychiatric findings may provide answers to the significance of cerebrospinal fluid abnormalities identified in these patients.
引用
收藏
页码:1538 / 1540
页数:3
相关论文
共 50 条
  • [1] CYTOLOGICAL AND IMMUNOGLOBULIN FINDINGS IN CEREBROSPINAL-FLUID OF SYMPTOMATIC AND ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS (HIV) SEROPOSITIVE PATIENTS
    HAGBERG, L
    FORSMAN, A
    NORKRANS, G
    RYBO, E
    SVENNERHOLM, L
    INFECTION, 1988, 16 (01) : 13 - 18
  • [2] EFFECT OF ANTIRETROVIRAL THERAPY ON THE CEREBROSPINAL-FLUID OF PATIENTS SEROPOSITIVE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS
    GULEVICH, SJ
    MCCUTCHAN, JA
    THAL, LJ
    KIRSON, D
    DURAND, D
    WALLACE, M
    MEHTA, P
    GRANT, I
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (09): : 1002 - 1007
  • [3] CEREBROSPINAL-FLUID ANALYSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    HALL, CD
    SNYDER, CR
    ROBERTSON, KR
    MESSENHEIMER, JA
    WILKINS, JW
    ROBERTSON, WT
    WHALEY, RA
    VANDERHORST, C
    SILVERMAN, LM
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1992, 22 (03): : 139 - 143
  • [4] ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS - EARLY LABORATORY MARKERS IN CEREBROSPINAL-FLUID AND BLOOD
    SINGER, E
    RUANE, P
    RESNICK, L
    SHAPSHAK, P
    SYNDULKO, K
    OSBORNE, M
    RUBINSHTEIN, G
    ROSARIO, I
    SCHMID, P
    TOURTELLOTTE, WW
    ANNALS OF NEUROLOGY, 1988, 24 (01) : 166 - 166
  • [5] STUDY OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE CEREBROSPINAL-FLUID - VALUE AND LIMITATIONS
    BUFFET, R
    AGUT, H
    HURAUX, JM
    PRESSE MEDICALE, 1991, 20 (24): : 1124 - 1128
  • [6] NEUROLOGIC ABNORMALITIES AND RECOVERY OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM CEREBROSPINAL-FLUID
    HOLLANDER, H
    LEVY, JA
    ANNALS OF INTERNAL MEDICINE, 1987, 106 (05) : 692 - 695
  • [7] EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN CEREBROSPINAL-FLUID OF CHILDREN WITH PROGRESSIVE ENCEPHALOPATHY
    EPSTEIN, LG
    GOUDSMIT, J
    PAUL, DA
    MORRISON, SH
    CONNOR, EM
    OLESKE, JM
    HOLLAND, B
    ANNALS OF NEUROLOGY, 1987, 21 (04) : 397 - 401
  • [8] CEREBROSPINAL-FLUID AND HUMAN IMMUNODEFICIENCY VIRUS
    SOUBEYRAND, J
    NIAMKEY, E
    TEA, D
    ABISSEY, A
    MALET, B
    LELEU, JP
    KADJO, K
    DIALLO, D
    ADOM, H
    BEDA, BY
    SEMAINE DES HOPITAUX, 1989, 65 (46): : 2781 - 2786
  • [9] EFFECT OF ANTIRETROVIRAL THERAPY ON THE CEREBROSPINAL-FLUID OF PATIENTS SEROPOSITIVE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS (VOL 6, PG 1002, 1993)
    GULEVICH, SJ
    MCCUTCHAN, JA
    THAL, LJ
    KIRSON, D
    DURAND, D
    WALLACE, M
    MEHTA, P
    HEYES, MP
    GRANT, I
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (09): : 994 - 994
  • [10] OUTCOMES IN A COHORT OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE MEN
    GOLDSMITH, J
    CHMIEL, J
    OSTROW, D
    PHAIR, J
    CLINICAL RESEARCH, 1986, 34 (04): : A962 - A962